Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP972278.RAbYkuqQUYGxU-MVXYnWVqK1xKjBFKcZZWdgn6prCcohg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP972278.RAbYkuqQUYGxU-MVXYnWVqK1xKjBFKcZZWdgn6prCcohg130_assertion type Assertion NP972278.RAbYkuqQUYGxU-MVXYnWVqK1xKjBFKcZZWdgn6prCcohg130_head.
- NP972278.RAbYkuqQUYGxU-MVXYnWVqK1xKjBFKcZZWdgn6prCcohg130_assertion description "[Triple-negative breast cancers (TNBC) are especially refractory to treatment due to their negative hormone receptor and ErbB2/HER2 status.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP972278.RAbYkuqQUYGxU-MVXYnWVqK1xKjBFKcZZWdgn6prCcohg130_provenance.
- NP972278.RAbYkuqQUYGxU-MVXYnWVqK1xKjBFKcZZWdgn6prCcohg130_assertion evidence source_evidence_literature NP972278.RAbYkuqQUYGxU-MVXYnWVqK1xKjBFKcZZWdgn6prCcohg130_provenance.
- NP972278.RAbYkuqQUYGxU-MVXYnWVqK1xKjBFKcZZWdgn6prCcohg130_assertion SIO_000772 22472120 NP972278.RAbYkuqQUYGxU-MVXYnWVqK1xKjBFKcZZWdgn6prCcohg130_provenance.
- NP972278.RAbYkuqQUYGxU-MVXYnWVqK1xKjBFKcZZWdgn6prCcohg130_assertion wasDerivedFrom befree-2016 NP972278.RAbYkuqQUYGxU-MVXYnWVqK1xKjBFKcZZWdgn6prCcohg130_provenance.
- NP972278.RAbYkuqQUYGxU-MVXYnWVqK1xKjBFKcZZWdgn6prCcohg130_assertion wasGeneratedBy ECO_0000203 NP972278.RAbYkuqQUYGxU-MVXYnWVqK1xKjBFKcZZWdgn6prCcohg130_provenance.